Dusp5 negatively regulates IL-33-mediated eosinophil survival and function

被引:51
作者
Holmes, Derek A. [1 ]
Yeh, Jung-Hua [1 ]
Yan, Donghong [2 ]
Xu, Min [2 ]
Chan, Andrew C. [1 ]
机构
[1] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Translat Immunol, San Francisco, CA 94080 USA
关键词
BCL-X-L; eosinophil survival; dual-specificity phosphatase 5; CELL-SURVIVAL; IL-33/ST2; AXIS; KAPPA-B; PROTEIN; EXPRESSION; INTERLEUKIN-33; MEPOLIZUMAB; CYTOKINE; INNATE; ASTHMA;
D O I
10.15252/embj.201489456
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitogen-activated protein kinase (MAPK) activation controls diverse cellular functions including cellular survival, proliferation, and apoptosis. Tuning of MAPK activation is counter-regulated by a family of dual-specificity phosphatases (DUSPs). IL-33 is a recently described cytokine that initiates Th2 immune responses through binding to a heterodimeric IL-33R (ST2L)/IL-1 accessory protein (IL-1RAcP) receptor that coordinates activation of ERK and NF-B pathways. We demonstrate here that DUSP5 is expressed in eosinophils, is upregulated following IL-33 stimulation and regulates IL-33 signaling. Dusp5(-/-) mice have prolonged eosinophil survival and enhanced eosinophil effector functions following infection with the helminth Nippostrongylus brasiliensis. IL-33-activated Dusp5(-/-) eosinophils exhibit increased cellular ERK1/2 activation and BCL-X-L expression that results in enhanced eosinophil survival. In addition, Dusp5(-/-) eosinophils demonstrate enhanced IL-33-mediated activation and effector functions. Together, these data support a role for DUSP5 as a novel negative regulator of IL-33-dependent eosinophil function and survival.
引用
收藏
页码:218 / 235
页数:18
相关论文
共 69 条
[1]   Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 [J].
Abraham, Sonya M. ;
Lawrence, Toby ;
Kleiman, Anna ;
Warden, Paul ;
Medghalchi, Mino ;
Tuckermann, Jan ;
Saklatvala, Jeremy ;
Clark, Andrew R. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (08) :1883-1889
[2]   Eosinophils and Disease Pathogenesis [J].
Akuthota, Praveen ;
Weller, Peter F. .
SEMINARS IN HEMATOLOGY, 2012, 49 (02) :113-119
[3]   MAP Kinase Phosphatase-2 Plays a Critical Role in Response to Infection by Leishmania mexicana [J].
Al-Mutairi, Mashael S. ;
Cadalbert, Laurence C. ;
McGachy, H. Adrienne ;
Shweash, Muhannad ;
Schroeder, Juliane ;
Kurnik, Magdalena ;
Sloss, Callum M. ;
Bryant, Clare E. ;
Alexander, James ;
Plevin, Robin .
PLOS PATHOGENS, 2010, 6 (11)
[4]  
[Anonymous], 2008, LAB INVEST, DOI DOI 10.1038/LABINVEST.2008.82
[5]  
Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397
[6]   Tumour cell survival signalling by the ERK1/2 pathway [J].
Balmanno, K. ;
Cook, S. J. .
CELL DEATH AND DIFFERENTIATION, 2009, 16 (03) :368-377
[7]   Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma [J].
Bel, Elisabeth H. ;
Wenzel, Sally E. ;
Thompson, Philip J. ;
Prazma, Charlene M. ;
Keene, Oliver N. ;
Yancey, Steven W. ;
Ortega, Hector G. ;
Pavord, Ian D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13) :1189-1197
[8]   IL-33 Markedly Activates Murine Eosinophils by an NF-κB-Dependent Mechanism Differentially Dependent upon an IL-4-Driven Autoinflammatory Loop [J].
Bouffi, Carine ;
Rochman, Mark ;
Zust, Christopher B. ;
Stucke, Emily M. ;
Kartashov, Andrey ;
Fulkerson, Patricia C. ;
Barski, Artem ;
Rothenberg, Marc E. .
JOURNAL OF IMMUNOLOGY, 2013, 191 (08) :4317-4325
[9]   Dual-specificity MAP kinase phosphatases (MKPs): Shaping the outcome of MAP kinase signalling [J].
Caunt, Christopher J. ;
Keyse, Stephen M. .
FEBS JOURNAL, 2013, 280 (02) :489-504
[10]   A novel IL-1 family cytokine, IL-33, potently activates human eosinophils [J].
Cherry, W. Brett ;
Yoon, Juhan ;
Barternes, Kathleen R. ;
Iijima, Koji ;
Kita, Hirohito .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (06) :1484-1490